Skip to content

A study on effectiveness of Bringaraja thailam for the management of sooli kanam

An pilot study to assess the effectiveness of Bringaraja thailam for the management of childhood bronchial asthma - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069090
Enrollment
10
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: Bringaraja thailam as internal medicine: Ingredients karisalai Eclipta alba Gingelly oil ROUTE OF ADMINISTRATION Internal DOSAGE 6 to 8 years 0.

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children of both sex in the age group of 6 to 12 years 2 Is diagnosed with asthma by following the Global Initiative for Asthma (GINA) guidelines and St Georges respiratory questionnaire 3 Children having FEV1 greater than 60 percentage TO less than 80 percentage 4 Patient willing to co-operate for spirometry test 5 Parent willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1 H/O Pulmonary tuberculosis 2 H/O Bronchiectasis 3 Subject unable to do Spirometry 4 Any other serious illness

Design outcomes

Primary

MeasureTime frame
Effectiveness of the trial drug will be assessed by spirometry by Comparing the values of forced expiratory volume after treatment from baselineTimepoint: Effectiveness of the trial drug will be assessed by spirometry before and after treatment

Secondary

MeasureTime frame
Improvement in the symptoms assessed by GINA Global Initiative for Asthma Guidelines 2022 and St Georges Respiratory questionnaire Timepoint: Before and after treatment

Countries

India

Contacts

Public ContactDr Karthika Prakasan

National institute of siddha

gvennils@gmail.com9789093986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026